News

• 

   21.07.2026

  Asthma: New Mechanism of Action Curbs Inflammatory Response

  A team from the University of Bonn and the Research Center Borstel, Leibniz Lung Center (FZB) has discovered a previously unknown mechanism of action for a synthetic peptide that mitigates excessive inflammatory responses in allergic asthma. This mechanism specifically inhibits a key inflammatory switch in the immune system and opens up new avenues for treating chronic inflammatory diseases. The findings have now been published in the journal Advanced Science.

• 

   20.07.2026

  New Research Group strengthens Functional Microbiome Research at FZB

  Prof. Dr. Amelia Barber has accepted the call to the W3 professorship for “Functional Microbiome Research in Chronic Lung Diseases” and since July 2026 is establishing a new research group at the Research Center Borstel, Leibniz Lung Center (FZB). With her expertise in fungal and microbiome research, she expands the scientific profile of FZB and builds a bridge between infection and chronic lung disease research.

• 

   20.07.2026

  Tuberculosis: An immune signature in the blood indicates whether treatment is working

  Researchers at the Research Center Borstel, Leibniz Lung Center (FZB) and the German Center for Infection Research (DZIF) have identified a novel whole blood-based immune signature that could improve both the diagnosis of pulmonary tuberculosis (TB) and the monitoring of treatment response.